NCT05201352
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05201352
Title Evaluation of Efficacy of Trifluridine/Tipiracil Plus an Anti-IL-1alpha True Human Antibody Versus Trifluridine/Tipiracil Plus Placebo in Metastatic Colorectal Cancer Patients After Failure of Oxaliplatin, Irinotecan, Fluoropyrimidine (TASKIN)
Acronym TASKIN
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Centre Georges Francois Leclerc
Indications
Therapies
Age Groups: senior | adult
Covered Countries FRA

Facility Status City State Zip Country Details
Centre Georges-François Leclerc Dijon Bourgogne-Franche-Comté 21000 France Details
CHU Dijon Dijon Bourgogne-Franche-Comté 21000 France Details
ICO Angers Angers 49055 France Details
Institut Sainte Catherine Avignon 84000 France Details
CHU Jean Minjoz Besançon 25000 France Details
Institut Bergonié Bordeaux 33000 France Details
Centre Hospitalier Carcassonne Carcassonne 11810 France Details
CHU Estaing Clermont-Ferrand 63003 France Details
Hopital Franco-Britannique Levallois-Perret 92300 France Details
CHU Dupuytren Limoges 87000 France Details
CHU Nantes Nantes 44000 France Details
Cario-Hpca Plérin 22190 France Details
Institut Jean Godinot Reims 51100 France Details
Institut de Cancérologie de l'Ouest Saint-Herblain 44805 France Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field